Medications
Sofosbuvir: Indication of added benefit for specific patients
The drug sofosbuvir has been available since January 2014 as a treatment for chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the ...
May 2, 2014
0
0
